|国家科技期刊平台
首页|期刊导航|器官移植|成人再次肝移植研究进展

成人再次肝移植研究进展OA北大核心CSTPCD

Research progress in adult liver retransplantation

中文摘要英文摘要

再次肝移植是肝移植术后移植肝衰竭的唯一治愈性手段.首次肝移植与再次肝移植间隔时间的长短,将直接影响成人再次肝移植的手术适应证、技术难度和治疗转归.既往多项研究认为再次肝移植术后移植肝及受者总体生存率明显低于首次肝移植,但随着器官保存方法、麻醉管理理念、重症监护策略、外科手术技术和新型免疫抑制药等各个领域的全面进步,成人再次肝移植的疗效显著提高.本文就成人再次肝移植手术适应证的变迁、手术时机的选择、长期疗效及其影响因素、手术技术难点、免疫抑制方案的选择以及活体再次肝移植的开展情况进行评述,总结目前成人肝移植取得的成果、面临的挑战及潜在解决方案,以期为提高成人再次肝移植的临床疗效提供参考.

Liver retransplantation is the final option for graft failure after liver transplantation.The interval between the first and second liver transplantation will directly affect surgical indications,technical diffiiculties and treatment outcomes of adult liver retransplantation.Previous studies have shown that the overall survival of liver allografts and recipients after liver retransplantation is significantly lower than that after the first liver transplantation.However,with comprehensive progress in organ preservation methods,anesthesia management concepts,intensive care strategies,surgical techniques and new immunosuppressive drugs,clinical efficacy of adult liver retransplantation has been significantly improved.In this article,the changes of indications,timing of operation,long-term effiicacy and its influencing factors,technical difficulties,selection of immunosuppressive regimens and the implementation of living donor liver retransplantation were reviewed,and the achievements,challenges and potential solutions of adult liver retransplantation were summarized,aiming to provide reference for enhancing clinical efficacy of adult liver retransplantation.

吴若林;赵红川;耿小平

230022 合肥,安徽医科大学第一附属医院肝胆胰及移植外科

临床医学

再次肝移植移植肝衰竭活体肝移植免疫抑制免疫诱导排斥反应手术并发症疾病复发

Liver retransplantationLiver graft failureLiving donor liver transplantationImmunosuppressionImmune inductionRejectionSurgical complicationDisease recurrence

《器官移植》 2024 (004)

563-569 / 7

安徽省自然科学基金青年基金项目(2008085QH361)

10.3969/j.issn.1674-7445.2024040

评论